-
, Surveillance & Exploration). This innovative initiative, established in 2024, is a collaboration between the University of Oxford and GlaxoSmithKline (GSK) aimed at identifying molecular vulnerabilities in
-
of research projects on human immunity against bacterial and viral infections using human challenge models. You will support the research of Post-Doctoral Scientists, whilst obtaining training in working
-
tomato and pepper as model systems. Work in Oxford will build on our extensive experience in studying bacterial virulence mechanisms and the role of the plant microenvironment in disease development
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
this hydrogen generation model with the ammonia synthesis module. Find out more about the Hayward research and group at: https://www.chem.ox.ac.uk/people/mike-hayward. About you Applicants must hold a
-
proteome in heart-specific cell lines and primary tissue. It will utilize disease model systems to characterize unique cell surface signatures for cardiomyocytes, coronary endothelial cells, and fibroblasts